# FDA Inspection 1180850 - Daito Pharmaceutical Co., Ltd. - September 16, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/daito-pharmaceutical-co-ltd/1366a9ac-53ce-420a-bc51-90ace49896f0
Source feed: FDA_Inspections

> FDA Inspection 1180850 for Daito Pharmaceutical Co., Ltd. on September 16, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180850
- Company Name: Daito Pharmaceutical Co., Ltd.
- Inspection Date: 2022-09-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1226666 - 2023-12-19](https://www.globalkeysolutions.net/records/fda_inspections/daito-pharmaceutical-co-ltd/f70a2428-1ef7-45a6-abe8-c8a8e761bbab)
- [FDA Inspection 748400 - 2011-09-29](https://www.globalkeysolutions.net/records/fda_inspections/daito-pharmaceutical-co-ltd/c6cec99e-7959-421c-93c8-a18ffdc22f23)

Company: https://www.globalkeysolutions.net/companies/daito-pharmaceutical-co-ltd/3a27bbaf-60c1-44b3-acf3-48f8935483e8

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c